Lung Cancer Symposium 2025

You are invited to join the 3rd annual Lung Cancer Symposium.

This symposium will focus on the progress of lung cancer screening projects in the Nordic countries as the key scientists from each country will present the status on this important subject. Norway, Denmark, Sweden, Finland and Iceland are represented.

Join this symposium and take part in discussions with experts as they frame the challenges of lung cancer and address clinical models for risk prediction, early diagnosis, cost effectiveness and screening plans in the Nordics. Could we learn from eachothers experiences? Could we find a good way to define high-risk individuals, invite them, screen and follow-up. Does AI play a role? What is the role of smoke cessation in screening and how to do that?

International experts from the Nordics, UK, and USA will share up-to-date experiences from their respective countries. A panel discussion will include implementation models for lung cancer screening, cost-effectiveness and CT screening. Is this the right time to implement?

Program (tentative)
09:00–09:10 Welcome & Introductions
Charlotte Homme, Head of Membership & Events, Oslo Cancer Cluster
Ingrid Stenstadvoll Ross, Secretary General, Norwegian Cancer Society OR Ole Alexander Opdalshei, Deputy Secretary General, Norwegian Cancer Society

09:10–09:30 The challenges and benefits of lung cancer screening
Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway. Lung Symposium, Chair, moderator.

09:30 - 09:50 UK – Lessons and Updates from the United Kingdom
David Baldwin, MD, PhD, Professor, Nottingham University Hospital. Nottingham, UK

09.50 – 10:10 Finland – Efforts and progress in lung cancer screening
Jussi Koivunen, MD, PhD, Professor, Department of Oncology and Radiotherapy, The Oulu University Hospital, Oulu, Finland

10:10-10:20 Coffee Break

10:20 – 10:40 Iceland – Lung cancer in Iceland
Hrönn Harðardóttir, Pulmonologist, Team Leader, Landspítali University Hospital, Reykjavik, Iceland

10:40 – 11:00 Denmark – Efforts and progress in lung cancer screening, Update on the PLUS Project
Michael Stenger, MD, PhD, Associate Professor, PLUS Project Director, Consultant Thoracic Surgeon, Svendborg Hospital, Odense, Denmark

11:00 – 11:20 Sweden - Efforts and progress in lung cancer screening
Mikael Johansson, Associate professor, Senior consultant, Dept of Diagnostics and Intervention, Oncology, Umeå University

11:20 – 12:10 Cultural and Networking Lunch

12:10 – 12:30 USA - Lung Cancer Screening in the United States: What Works, What Doesn’t
Florian Fintelmann, MD, Associate Professor, Massachusetts General Hospital, Boston (Digital)

12:30–12:50 Health and economic considerations of lung cancer screening: A Norwegian Perspective
Emily Anikka Burger, PhD, Professor, Department of Health Management and Health Economics, Faculty of Medicine, University of Oslo & Research Scientist Harvard T.H. Chan School of Public Health

12:50 – 13:00 Coffee Break

13:00 – 13:45 Norway – E-Lung Study, Innovative Models for Screening Selection and Smoking Cessation Progress Report and the TIDL Study
Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway
Trond-Eirik Strand, PhD, Professor II, Special Advisor, Oslo University Hospital

13:45 – 14:45 Panel Discussion and Conclusions: This is the right time to implement lung cancer screening in Norway
Panelists, All speakers, plus stakeholders.

14:45 – 15:00 Closing Remarks

The symposium is organised by; Oslo Cancer Cluster & Levanger Hospital, Norwegian University of Science & Technology